Reference Product Substitution
Reference Product Substitution is a regulatory and methodological framework within pharmaceutical policy that identifies a designated approved drug product used as the basis for evaluating the therapeutic equivalence of generic or follow-on drugs in lieu of an original reference listed drug.
18
Publications
568
Citations
143
Authors
66
Institutions
Publications per year
2017–2026
9
18
Jeremiah D. Momper, Ty A. Ridenour, Kristine S. Schonder et al. · American Journal of Transplantation · 2011 · 77 citations · Full text
Ylenia Ingrasciotta, Francesco Giorgianni, Ilaria Marcianò et al. · PLoS ONE · 2016 · 40 citations · Full text
Pharmacy, Hematology, Pharmacology +16
1–5 of 18
143
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 143
66

Universitat Autònoma de Barcelona
Cerdanyola del Vallès, Spain
2 h-index
2 publications
32 citations
Hospital Universitario de Fuenlabrada
Fuenlabrada, Spain
1 h-index
1 publications
38 citations
Ben-Gurion University of the Negev
Beersheba, Israel
1 h-index
1 publications
14 citations

University of Bologna
Bologna, Italy
1 h-index
4 publications
180 citations

Hospital de Sant Pau
Barcelona, Spain
1 h-index
1 publications
14 citations
Vall d'Hebron Hospital Universitari
Barcelona, Spain
1 h-index
1 publications
18 citations
Palo Alto University
Palo Alto, United States
1 h-index
1 publications
14 citations
Hospital Central de la Defensa Gómez Ulla
Madrid, Spain
1 h-index
1 publications
38 citations
1–8 of 66
JMCP · 2 publications · 41 citations
2
h-index
1 publications · 18 citations
1
h-index
1 publications · 28 citations
1
h-index
CPT · 1 publications · 13 citations
1
h-index
1 publications · 30 citations
1
h-index
1–5